Table 1. (B) Baseline characteristics of included studies.
| Author | Hematoma volume (ml) | Time of laboratory test | Main cut-off value | Other cut-off values | poor outcome (OR)# | mortality (OR)# | Follow up |
|---|---|---|---|---|---|---|---|
| Tao, C. | 15.8 | admission | 6.62 | - | 2.6 (1.4–4.7) | 5.1 (2.6–8.6) | 90-day |
| Sun, Y. | 10.7 | non-admission | 4.08 | 7.85 | 0.93 (0.34–2.57) 1.83 (0.62–5.39) |
1.51 (0.34–6.61) 0.64 (0.15–2.76) |
90-day 90-day |
| Giede-Jeppe, A. | 14.4 | admission | 4.66 4.66 |
8.508 | 0.983 (0.939–1.029) 2.251 (1.543–3.282)* |
0.967 (0.939–0.997) 0.974 (0.945–1.004) 1.626 (1.186–2.231)* |
In-hospital 90-day 90-day |
| Wang, F. | 14.9 | non-admission admission |
7.35 7.35 |
- | – | 1.091 (1.002–1.188) 0.852 (0.608–1.194) |
In-hospital In-hospital |
| Lattanzi, S. | 8.1 | admission | 4.58 | - | 1.16 (1.01–1.33) | – | 90-day |
#: multivariate regression analysis, *: univariate regression analysis, OR: odds ratio.